HR-Positive Breast Cancer: Jenna's Patient Story
This breast cancer diagnosis at a glance
- Biomarkers
- ER-positive
- Sex
- Female
- Treatment
- chemotherapy, surgery, hormone therapy and reconstruction
- Outcome
- Care Ongoing
Treatment course, step by step
- Chemotherapy began at 32 weeks of pregnancy; delivery of a healthy baby boy at 37 weeks; 10 rounds of intensive chemotherapy; double mastectomy; reconstructive surgery planned; tamoxifen planned for 10 or more years.
What happened, in summary
Jenna was 34 and pregnant when she found a breast lump that she initially thought was a clogged milk duct. Ultrasound and an urgent biopsy confirmed breast cancer with spread to lymph nodes. A second opinion agreed that treatment needed to begin quickly. Because the cancer was estrogen-receptor positive and pregnancy limited staging imaging, her oncology and obstetric teams recommended starting chemotherapy before delivery.
She began chemotherapy at 32 weeks of pregnancy and gave birth to a healthy baby boy at 37 weeks. Jenna then completed 10 rounds of intensive chemotherapy, with severe side effects and allergic reactions, while also caring for a newborn and a two-year-old. Hair loss, weight gain, pain, and the physical recovery from childbirth changed how she saw her body and identity.
After chemotherapy, Jenna underwent a double mastectomy. Exercise helped her rebuild strength and eventually hold her children comfortably again. Reconstructive surgery was planned, along with tamoxifen for 10 years or longer. Although she worried about treatment-related menopause and possible effects on future fertility, she was focused on recovery, motherhood, and creating a new sense of identity after cancer.
Where this story comes from
This is a lay summary of an account first published by breastcancer.org. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer